NEW YORK (GenomeWeb News) - The US Department of Defense has terminated a pathogen-identification technology contract with Applied Biosystems because the company and the US Air Force could not agree on the best route for commercializing the product, ABI said Friday. 
 
The DOD awarded ABI a $24.5 million contract last August to develop a prototype system that would identify infectious diseases for epidemiological and biosecurity purposes.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.